Zobrazeno 1 - 10 of 45 pro vyhledávání: '"Kristin Hannesdottir"'
2
Akademický článek
Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study
Autor: Jelena Curcic, Vanessa Vallejo, Jennifer Sorinas, Oleksandr Sverdlov, Jens Praestgaard, Mateusz Piksa, Mark Deurinck, Gul Erdemli, Maximilian Bügler, Ioannis Tarnanas, Nick Taptiklis, Francesca Cormack, Rebekka Anker, Fabien Massé, William Souillard-Mandar, Nathan Intrator, Lior Molcho, Erica Madero, Nicholas Bott, Mieko Chambers, Josef Tamory, Matias Shulz, Gerardo Fernandez, William Simpson, Jessica Robin, Jón G Snædal, Jang-Ho Cha, Kristin Hannesdottir
Publikováno v: JMIR Research Protocols, Vol 11, Iss 8, p e35442 (2022)
BackgroundMore sensitive and less burdensome efficacy end points are urgently needed to improve the effectiveness of clinical drug development for Alzheimer disease (AD). Although conventional end points lack sensitivity, digital technologies hold pr
Externí odkaz: https://doaj.org/article/e3350c32a2b146b7b2079f8e8be5bd3b
Zobrazit plný text záznamu
3
Akademický článek
Remote monitoring technologies in Alzheimer’s disease: design of the RADAR-AD study
Autor: Marijn Muurling, Casper de Boer, Rouba Kozak, Dorota Religa, Ivan Koychev, Herman Verheij, Vera J. M. Nies, Alexander Duyndam, Meemansa Sood, Holger Fröhlich, Kristin Hannesdottir, Gul Erdemli, Federica Lucivero, Claire Lancaster, Chris Hinds, Thanos G. Stravopoulos, Spiros Nikolopoulos, Ioannis Kompatsiaris, Nikolay V. Manyakov, Andrew P. Owens, Vaibhav A. Narayan, Dag Aarsland, Pieter Jelle Visser, the RADAR-AD Consortium
Publikováno v: Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-13 (2021)
Abstract Background Functional decline in Alzheimer’s disease (AD) is typically measured using single-time point subjective rating scales, which rely on direct observation or (caregiver) recall. Remote monitoring technologies (RMTs), such as smartp
Externí odkaz: https://doaj.org/article/bd954175d4554161ab2213815691bcc2
Zobrazit plný text záznamu
4
Akademický článek
A Study of Novel Exploratory Tools, Digital Technologies, and Central Nervous System Biomarkers to Characterize Unipolar Depression
Autor: Oleksandr Sverdlov, Jelena Curcic, Kristin Hannesdottir, Liangke Gou, Valeria De Luca, Francesco Ambrosetti, Bingsong Zhang, Jens Praestgaard, Vanessa Vallejo, Andrew Dolman, Baltazar Gomez-Mancilla, Konstantinos Biliouris, Mark Deurinck, Francesca Cormack, John J. Anderson, Nicholas T. Bott, Ziv Peremen, Gil Issachar, Offir Laufer, Dale Joachim, Raj R. Jagesar, Niels Jongs, Martien J. Kas, Ahnjili Zhuparris, Rob Zuiker, Kasper Recourt, Zoë Zuilhof, Jang-Ho Cha, Gabriel E. Jacobs
Publikováno v: Frontiers in Psychiatry, Vol 12 (2021)
Background: Digital technologies have the potential to provide objective and precise tools to detect depression-related symptoms. Deployment of digital technologies in clinical research can enable collection of large volumes of clinically relevant da
Externí odkaz: https://doaj.org/article/72fd564b566f4cc386cf603a160ea3ee
Zobrazit plný text záznamu
9
The OutSMARTers Program for Children With ADHD
Autor: Dagmar Kristin Hannesdottir, Ester Ingvarsdottir, Andri S. Bjornsson
Publikováno v: Journal of Attention Disorders. 21:353-364
Objective: This study examined the effects of the OutSMARTers program on social skills, self-regulation, and executive functions compared with a Waitlist group and a parent training program. Method: Participants were 41 children with ADHD, aged 8 to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e73513f0036070dd277b13dec9762d17
https://doi.org/10.1177/1087054713520617
Zobrazit plný text záznamu
10
Clinically Meaningful Outcomes in Early Alzheimer Disease: A Consortia-Driven Approach to Identifying What Matters to Patients
Autor: Kristin Hannesdottir, Mark Forrest Gordon, Diane Stephenson, Michael T. Ropacki, Robert S. Stern, Suzanne Hendrix, Stephen Joel Coons
Publikováno v: Therapeutic innovationregulatory science. 51(3)
Numerous statistically derived composite measures have recently been proposed as clinical outcome assessments (COAs) for clinical trials in the early stages of Alzheimer disease. Critical Path Institute's Coalition Against Major Diseases (CAMD) advan
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b915337da526988001d835fcf0c6ade
https://pubmed.ncbi.nlm.nih.gov/30231712
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje